These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36422998)

  • 1. Biologic treatment of psoriasis in oncologic patients.
    Rusiñol L; Camiña-Conforto G; Puig L
    Expert Opin Biol Ther; 2022 Dec; 22(12):1567-1578. PubMed ID: 36422998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durability and long-term outcomes of biologic therapies in psoriasis.
    Rusiñol L; Carmona-Rocha E; Puig L
    Expert Rev Clin Immunol; 2024; 20(1):71-82. PubMed ID: 37610817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study.
    Battista T; Gallo L; Martora F; Fattore D; Potestio L; Cacciapuoti S; Scalvenzi M; Megna M
    J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610706
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.
    Borren NZ; Ananthakrishnan AN
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1736-1743.e4. PubMed ID: 30616024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major cardiovascular events under biologic psoriasis therapies: a 19-year real-world analysis of FAERS data.
    Ding L; Chen C; Yang Y; Zhang X
    Front Immunol; 2024; 15():1349636. PubMed ID: 38384460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics.
    Prignano F; Pescitelli L; Trovato E; DI Cesare A; Cuccia A; Mazzatenta C; Pellegrino M; Marsili F; Castelli A; Brandini L; Niccoli MC; Taviti F; Ricceri F; Panduri S; Buggiani G; Ghilardi A; Rubegni P; Romanelli M; Pimpinelli N
    Ital J Dermatol Venerol; 2022 Dec; 157(6):469-479. PubMed ID: 35785927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe and acute complications of biologics in psoriasis.
    Oussedik E; Patel NU; Cash DR; Gupta AS; Feldman SR
    G Ital Dermatol Venereol; 2017 Dec; 152(6):586-596. PubMed ID: 28895664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapies versus first-generation biologic drugs in psoriasis: a review of adverse events and their management.
    Carrascosa JM; Del-Alcazar E
    Expert Rev Clin Immunol; 2018 Apr; 14(4):259-273. PubMed ID: 29557200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real-life data from the BiPe cohorts and a practice survey among French and Italian pediatric dermatologists.
    Mahé E; Beauchet A; Hadj-Rabia S; Mazereeuw-Hautier J; Mallet S; Phan A; Severino-Freire M; Boralevi F; Aubert H; Barthélémy H; Girard C; Martin L; Piram M; Barbarot S; Balguerie X; Zitouni J; Phan C; Di Lernia V;
    Dermatol Ther; 2022 Nov; 35(11):e15828. PubMed ID: 36107157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of
    Feng Y; Zhou B; Wang Z; Xu G; Wang L; Zhang T; Zhang Y
    Int J Clin Pract; 2022; 2022():2442603. PubMed ID: 36212052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are biosimilars approved for use in psoriasis safe enough to replace leading biologic therapies? A review.
    Reynolds KA; Pithadia DJ; Lee EB; Han G; Wu JJ
    Expert Opin Drug Saf; 2020 Apr; 19(4):459-466. PubMed ID: 32116071
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of genital and oral human papillomavirus infection among psoriasis patients on biologic therapy.
    Rob F; Hugo J; Saláková M; Šmahelová J; Gkalpakiotis S; Boháč P; Tachezy R
    Dermatol Ther; 2022 Oct; 35(10):e15735. PubMed ID: 35883191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologics in the treatment of pustular psoriasis.
    Wang WM; Jin HZ
    Expert Opin Drug Saf; 2020 Aug; 19(8):969-980. PubMed ID: 32615817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Effects of Biologics on Renal Function in Psoriatic Patients: A Retrospective Study.
    Chen CB; Huang YT; Hsiao CC; Chang SH; Chi CC
    BioDrugs; 2022 Sep; 36(5):657-666. PubMed ID: 35994233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considering a Biologic: What's a Clinician to Do? Management of Biologics in Surgery, Vaccinations, and Cancer.
    Jin A; Zaladonis AG; Hsu S
    Skinmed; 2021; 19(1):17-19. PubMed ID: 33658108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QuantiFERON TB-gold conversion rate among psoriasis patients under biologics: a 9-year retrospective study.
    Megna M; Ferrillo M; Ruggiero A; Cinelli E; Gallo L; Fabbrocini G
    Int J Dermatol; 2021 Mar; 60(3):352-357. PubMed ID: 32989759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis.
    Singh S; Murad MH; Fumery M; Sedano R; Jairath V; Panaccione R; Sandborn WJ; Ma C
    Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):1002-1014. PubMed ID: 34688373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
    Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
    J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma Risk in Patients Treated With Biologic Therapy for Common Inflammatory Diseases: A Systematic Review and Meta-analysis.
    Esse S; Mason KJ; Green AC; Warren RB
    JAMA Dermatol; 2020 Jul; 156(7):787-794. PubMed ID: 32432649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in body weight and body mass index in psoriasis patients receiving biologics: A systematic review and network meta-analysis.
    Wu MY; Yu CL; Yang SJ; Chi CC
    J Am Acad Dermatol; 2020 Jan; 82(1):101-109. PubMed ID: 31400455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.